Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-05-28 06:01:11
Reporting Period:
Accepted Time:
2019-05-28 06:01:11
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
949858 Achieve Life Sciences Inc. ACHV In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713369 Alistair Richard Stewart 520 Pike Street
Suite 2250
Seattle WA 98101
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-23 17,500 $3.61 212,530 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,186 Indirect By Spouse
Common Stock 17,641 Indirect By Ricanto Limited
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6016 to $3.61 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The reporting holder is a principal owner of Ricanto Limited.